Howard D. Fabing

Frenquel, a Blocking Agent Against Experimental LSD‐25 and Mescaline Psychosis

Neurology May 1, 1955 Howard D. Fabing 41 citations

Background: Patients with ALS commonly exhibit pseudobulbar affect. Methods: The authors conducted a multicenter, randomized, double-blind, controlled, parallel, three-arm study to test a defined combination of dextromethorphan hydrobromide (DM) and quinidine sulfate (Q) (AVP-923) for the treatment of pseudobulbar affect in ALS. Q inhibits the rapid first-pass metabolism of DM. The effects of...